全文获取类型
收费全文 | 122240篇 |
免费 | 13668篇 |
国内免费 | 7580篇 |
专业分类
耳鼻咽喉 | 1149篇 |
儿科学 | 1944篇 |
妇产科学 | 988篇 |
基础医学 | 8533篇 |
口腔科学 | 2421篇 |
临床医学 | 16517篇 |
内科学 | 13266篇 |
皮肤病学 | 1485篇 |
神经病学 | 3848篇 |
特种医学 | 4678篇 |
外国民族医学 | 17篇 |
外科学 | 10516篇 |
综合类 | 29963篇 |
现状与发展 | 26篇 |
预防医学 | 14682篇 |
眼科学 | 1955篇 |
药学 | 13198篇 |
158篇 | |
中国医学 | 11211篇 |
肿瘤学 | 6933篇 |
出版年
2024年 | 627篇 |
2023年 | 2001篇 |
2022年 | 4222篇 |
2021年 | 5342篇 |
2020年 | 4701篇 |
2019年 | 2770篇 |
2018年 | 3297篇 |
2017年 | 3905篇 |
2016年 | 3252篇 |
2015年 | 5436篇 |
2014年 | 6822篇 |
2013年 | 8053篇 |
2012年 | 10454篇 |
2011年 | 10932篇 |
2010年 | 9503篇 |
2009年 | 8509篇 |
2008年 | 8449篇 |
2007年 | 8290篇 |
2006年 | 7345篇 |
2005年 | 5931篇 |
2004年 | 4354篇 |
2003年 | 3871篇 |
2002年 | 3142篇 |
2001年 | 2914篇 |
2000年 | 2003篇 |
1999年 | 1260篇 |
1998年 | 770篇 |
1997年 | 786篇 |
1996年 | 694篇 |
1995年 | 571篇 |
1994年 | 498篇 |
1993年 | 381篇 |
1992年 | 285篇 |
1991年 | 276篇 |
1990年 | 232篇 |
1989年 | 234篇 |
1988年 | 193篇 |
1987年 | 161篇 |
1986年 | 155篇 |
1985年 | 123篇 |
1984年 | 90篇 |
1983年 | 94篇 |
1982年 | 71篇 |
1981年 | 77篇 |
1980年 | 48篇 |
1979年 | 28篇 |
1978年 | 25篇 |
1977年 | 36篇 |
1976年 | 32篇 |
1954年 | 20篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
61.
Dr. S. Eggstein MD G. Manthey MT T. Hirsch PhD F. Baas MA B. U. V. Specht MD E. H. Farthmann MD 《Digestive diseases and sciences》1996,41(6):1069-1075
Epidermal growth factor receptors (EGFR) andras mutations are known to play a significant role in controlling cell growth and tumor promotion. Both of them transmit mitogenic signals to the nucleus by activation of Raf-1 kinase. In this study, the expression of EGFR and mutant Ras proteins, and, for the first time, the expression, phosphorylation and kinase activity of Raf-1 kinase have been determined in paired samples of colorectal cancer and mucosa. The tumor and mucosa samples did not differ significantly with regard to Raf-1 kinase content and activity. A major difference between tumors and mucosa was found, however, in the phosphorylation of Raf-1. Most of the mucosa samples (13/20), but only 1/20 of the cancer samples, contained hyperphosphorylated Raf-1. EGFR were significantly (p=0.0025) decreased in the tumors. The decreased phosphorylation of Raf-1 in colonic carcinomas could be the result of activation of Raf-1 phosphatases or inactivation of kinases phosphorylating Raf-1. New forms of treatment based on EGFR overexpression do not seem to be suitable for the majority of colonic cancers.This work was supported by the state of Baden-Württemberg (Verbundforschungsprojekt: Aufklärung von Mechanismen der Tumorentstehung und Tumorabwehr). 相似文献
62.
Marek Motyka PhD Helena Motyka MA RN Romana Wsoek MA RN 《Journal of advanced nursing》1997,26(5):909-912
The paper presents the results of a pilot study which involved 50 nurses from several departments of internal medicine of The State Clinical Hospital of the Collegium Medicum, Jagiellonian University in Cracow. The results are based on the Statement Response Questionnaire. They show that the most common responses of the nurses in the face of anxiety expressed by patients are cheering up the patient, collecting information about the symptom, and offering explanation of the symptom. The least common responses included expressing one's own positive emotions and showing empathy towards the patient. 相似文献
63.
64.
采用SD大鼠慢性肾血管性高血压模型,气-液色谱法测定高血压组(n=8)、对照组(n=9)脑细胞膜游离脂肪酸(Free Fatty Acid,FFA)单组分水平。结果显示高血压组脑细胞膜FFA组份中C20:4、C22:6水平显著高于对照组(PO.05)。提示继发性高血压大鼠存在脑细胞膜FFA代谢障碍。 相似文献
65.
1992~1993年间为180例冠脉病变的病人施行冠脉搭桥术,全部病人均采用核甙抑制剂利多氟嗪预处理和低温(28℃)间断缺血心停搏进行术中心肌保护。平均每例病人作冠状动脉端吻合3~4个,每个吻合口用9分钟,主动脉阻断累加时间约25分钟,体外循环时间90分钟,术后医院死亡率1.6%(3/180),无术后心梗发生。作者认为,冠脉搭桥术的术中心肌保护可采用核甙抑制剂和间断缺血心停搏方法,而不用心肌停搏液。 相似文献
66.
67.
CM Reid M. Nelson P. Beckinsale P. Ryan LMH Wing LJ Beilin MA Brown GLR Jennings CI Johnston J. Marley JJ McNeil TO Morgan J. Shaw ID Steven MJ West 《Clinical and experimental pharmacology & physiology》1997,24(5):370-373
1. The present study aimed to determine the feasibility of conducting a 5 year cardiovascular outcome trial of the treatment of 6000 elderly hypertensive patients in Australian general practices. 2. General practitioners (GPs) were invited to participate by mail and personal follow-up. Patient records were reviewed to identify subjects for a blood pressure (BP) screening programme. Blood pressure was measured on three occasions and eligible subjects were included if the average BP was 160 mmHg systolic or 90 mmHg diastolic if systolic BP was 140 mmHg. 3. Seven hundred and forty-one GPs were approached and 89 were enrolled in the study (12% of mail invites and 75% of those receiving a personal contact). In 16 practices where screening was completed, 82 000 records were reviewed to identify 4% patients eligible for screening. Twenty-two per cent of eligible subjects attended screening. Of 1938 subjects screened, 180 (9%) had BP 5=160/90 mmHg. Forty-seven percent of subjects (n = 916) were receiving antihypertensive therapy and 184 (20%) were withdrawn from therapy. One hundred and sixteen (63%) of these subjects had BP return to study entry levels within 6 weeks. Fifty-seven newly diagnosed and 81 previously treated subjects were randomized (7% of the screened population). 4. Based on the high participation rate of GPs, the response rate of patients to attend a BP screening programme and the 7% randomization to screening ratio for entry into the study, the ANBP2 pilot study has demonstrated that it is feasible to recruit subjects from Australian general practices to a cardiovascular outcome trial. 相似文献
68.
69.
大鼠肝细胞Ⅰ,Ⅲ型前胶原基因表达及PDGF的影响 总被引:3,自引:1,他引:2
目的观察大鼠肝细胞Ⅰ,Ⅲ型前胶原基因的表达及PDGF对其表达的影响.方法应用原位杂交技术检测分离培养的SD大鼠肝细胞(n=30)内Ⅰ,Ⅲ型前胶原基因的表达.同时观察10μg/L(n=30)和30μg/L(n=30)PDGF促进前胶原基因表达的作用.测定基因表达颗粒总面积占细胞总面积的百分比,并作比较分析.结果无论正常肝细胞或是在两种浓度的PDGF存在时,肝细胞内均可见到Ⅰ,Ⅲ型前胶原基因的表达.正常肝细胞Ⅰ,Ⅲ型前胶原基因表达面积的百分比(%)为77±19和75±21;加10μg/LPDGF后为115±19和112±10,而加30μg/L后为152±34及181±28,且在后者中表达明显增强(P<005及P<001).结论PDGF在转录水平上促进肝细胞胶原的合成. 相似文献
70.
Hartley Dean MA PhD Keir Gale BA Roger Woods BA MA 《Health & social care in the community》1996,4(6):338-346
The new complaints procedures which local authority social services departments have been required to introduce represent an important mechanism for managing the change of culture associated with recent community care reforms. They also represent a new genre in mechanisms of redress for welfare recipients. This paper reports the findings of a study which has observed considerable diversity in the ways in which local authorities are interpreting the nature and purposes of the new procedures and, in particular, the functions of review panels established under those procedures. Variations in the composition of panels, in the style of review panel proceedings, in perceptions of the panels' powers, and in the ways that complaints and complainants are constituted are all discussed. Attention is drawn to four competing interpretations of the review panels' role and to the need for these to be clarified and prioritised. 相似文献